Common Contracts

QUIDEL CORPORATION as Issuer AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee First Supplemental Indenture Dated as of December 8, 2014 to Indenture Dated as of December 1, 2014 3.25% Convertible Senior Notes due 2020

First Supplemental Indenture • December 8th, 2014 • Quidel Corp /De/ • In vitro & in vivo diagnostic substances • New York

• Contract Type
  First Supplemental Indenture
• Filed
  December 8th, 2014
• Company
  Quidel Corp /De/
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  New York

FIRST SUPPLEMENTAL INDENTURE, dated as of December 8, 2014, between Quidel Corporation, a corporation duly organized and existing under the laws of the State of Delaware, as issuer (the “Company”), having its principal office at 12544 High Bluff Drive, Suite 200, San Diego, California 92130, and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”) to the Indenture dated as of December 1, 2014, between the Company and the Trustee (the “Original Indenture”; the Original Indenture as amended and supplemented hereby and as it may be further amended and supplemented in accordance herewith and therewith, with respect to the Notes, the “Indenture”).

ENDOLOGIX, INC. as Issuer AND WELLS FARGO BANK, NATIONAL ASSOCIATION as Trustee First Supplemental Indenture Dated as of December 10, 2013 to Indenture Dated as of December 10, 2013 2.25% Convertible Senior Notes due 2018

First Supplemental Indenture • December 10th, 2013 • Endologix Inc /De/ • Surgical & medical instruments & apparatus • New York

• Contract Type
  First Supplemental Indenture
• Filed
  December 10th, 2013
• Company
  Endologix Inc /De/
• Industry
  Surgical & medical instruments & apparatus
• Jurisdiction
  New York

FIRST SUPPLEMENTAL INDENTURE, dated as of December 10, 2013, between Endologix, Inc., a corporation duly organized and existing under the laws of the State of Delaware, as issuer (the “Company”), having its principal office at 11 Studebaker, Irvine, California 92618, and Wells Fargo Bank, National Association, as trustee (the “Trustee”) to the Indenture dated as of December 10, 2013, between the Company and the Trustee (the “Original Indenture”; the Original Indenture as amended and supplemented hereby and as it may be further amended and supplemented in accordance herewith and therewith, with respect to the Notes, the “Indenture”).

MEDIVATION, INC. as Issuer AND WELLS FARGO BANK, NATIONAL ASSOCIATION as Trustee First Supplemental Indenture Dated as of March 19, 2012 to Indenture Dated as of March 19, 2012 2.625% Convertible Senior Notes due 2017

First Supplemental Indenture • March 19th, 2012 • Medivation, Inc. • Pharmaceutical preparations • New York

• Contract Type
  First Supplemental Indenture
• Filed
  March 19th, 2012
• Company
  Medivation, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

FIRST SUPPLEMENTAL INDENTURE, dated as of March 19, 2012, between Medivation, Inc., a corporation duly organized and existing under the laws of the State of Delaware, as issuer (the “Company”), having its principal office at 201 Spear Street, 3rd Floor, San Francisco, California 94105, and Wells Fargo Bank, National Association, a national banking association, as trustee (the “Trustee”) to the Indenture dated as of March 19, 2012, between the Company and the Trustee (the “Original Indenture”; the Original Indenture as amended and supplemented hereby and as it may be further amended and supplemented in accordance herewith and therewith, with respect to the Notes, the “Indenture”).